| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 12.139 | 7.495 | 2.820 | 1.118 | 1.333 | 7.401 | 10.727 | 11.725 | 10.936 |
| Total Income - EUR | - | 12.139 | 7.495 | 2.820 | 1.118 | 1.333 | 7.401 | 10.727 | 11.725 | 10.936 |
| Total Expenses - EUR | - | 2.990 | 4.667 | 5.630 | 5.969 | 6.487 | 6.787 | 7.235 | 8.291 | 10.025 |
| Gross Profit/Loss - EUR | - | 9.149 | 2.827 | -2.810 | -4.852 | -5.153 | 613 | 3.492 | 3.435 | 911 |
| Net Profit/Loss - EUR | - | 9.027 | 2.753 | -2.838 | -4.863 | -5.167 | 539 | 3.385 | 3.317 | 802 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Minismab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 9.403 | 10.428 | 4.472 | 270 | 652 | 1.199 | 2.575 | 5.173 | 6.301 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 51 | 51 | 0 |
| Cash | - | 9.403 | 10.428 | 4.472 | 270 | 652 | 1.199 | 2.525 | 5.122 | 6.301 |
| Shareholders Funds | - | 9.072 | 2.796 | -2.795 | -7.604 | -12.626 | -11.807 | -8.459 | -5.116 | -4.286 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 332 | 7.631 | 7.267 | 7.874 | 13.279 | 13.006 | 11.035 | 10.289 | 10.587 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6311 - 6311" | |||||||||
| CAEN Financial Year |
6311
|
|||||||||
Comments - Minismab S.r.l.